05:28 AM EDT, 06/14/2024 (MT Newswires) -- Avidity Biosciences ( RNA ) said late Thursday it priced an offering of almost 10.6 million shares at $38 apiece for expected gross proceeds of $400.9 million.

The company granted underwriters a 30-day option to purchase up to about 1.6 million additional shares in the offering.

The sale will likely close on or about June 17.

Price: 39.55, Change: -0.41, Percent Change: -1.03